171 related articles for article (PubMed ID: 32818321)
1. Risk of hematological malignancy in blood donors: A nationwide cohort study.
Zhao J; Dahlén T; Brynolf A; Edgren G
Transfusion; 2020 Nov; 60(11):2591-2596. PubMed ID: 32818321
[TBL] [Abstract][Full Text] [Related]
2. Trends in hematological cancer in the elderly in Denmark, 1980-2012.
Ocias LF; Larsen TS; Vestergaard H; Friis LS; Abildgaard N; Frederiksen H;
Acta Oncol; 2016; 55 Suppl 1():98-107. PubMed ID: 26783877
[TBL] [Abstract][Full Text] [Related]
3. Alcohol consumption has a protective effect against hematological malignancies: a population-based study in Sweden including 420,489 individuals with alcohol use disorders.
Ji J; Sundquist J; Sundquist K
Neoplasia; 2014 Mar; 16(3):229-34, 234.e1. PubMed ID: 24783999
[TBL] [Abstract][Full Text] [Related]
4. A population level analysis of second hematological malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma survivors in the era of targeted therapies.
Mishra R; Dima D; Kumar SA; Mian A; Taneja A; Karna R; Caimi PF; Hill BT; Dean R; Jagadeesh D
Hematol Oncol; 2023 Dec; 41(5):884-893. PubMed ID: 37309225
[TBL] [Abstract][Full Text] [Related]
5. Estimating the risk of developing secondary hematologic malignancies in patients with T1/T2 prostate cancer undergoing diverse treatment modalities: A large population-based study.
Mo X; Zhou M; Yan H; Chen X; Wang Y
Cancer Med; 2021 Aug; 10(15):5338-5346. PubMed ID: 34189859
[TBL] [Abstract][Full Text] [Related]
6. Secondary hematopoietic malignancies in survivors of childhood cancer: an analysis of 111 cases from the Surveillance, Epidemiology, and End Result-9 registry.
Rihani R; Bazzeh F; Faqih N; Sultan I
Cancer; 2010 Sep; 116(18):4385-94. PubMed ID: 20549819
[TBL] [Abstract][Full Text] [Related]
7. Risk of primary haematologic cancers following incident non-metastatic breast cancer: A Danish population-based cohort study.
Hjorth CF; Farkas DK; Schapira L; Cullen MR; Sørensen HT; Cronin-Fenton D
Cancer Epidemiol; 2023 Feb; 82():102311. PubMed ID: 36508968
[TBL] [Abstract][Full Text] [Related]
8. Cost of Disease Progression in Patients with Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non-Hodgkin's Lymphoma.
Reyes C; Engel-Nitz NM; DaCosta Byfield S; Ravelo A; Ogale S; Bancroft T; Anderson A; Chen M; Matasar M
Oncologist; 2019 Sep; 24(9):1219-1228. PubMed ID: 30808814
[TBL] [Abstract][Full Text] [Related]
9. Higher Risk for Hematological Malignancies in Inflammatory Bowel Disease: A Nationwide Population-based Study in Taiwan.
Wang LH; Yang YJ; Cheng WC; Wang WM; Lin SH; Shieh CC
Am J Gastroenterol; 2016 Sep; 111(9):1313-9. PubMed ID: 27296944
[TBL] [Abstract][Full Text] [Related]
10. Anthropometric characteristics, physical activity and risk of hematological malignancies: A systematic review and meta-analysis of cohort studies.
Psaltopoulou T; Sergentanis TN; Ntanasis-Stathopoulos I; Tzanninis IG; Riza E; Dimopoulos MA
Int J Cancer; 2019 Jul; 145(2):347-359. PubMed ID: 30614529
[TBL] [Abstract][Full Text] [Related]
11. Copper levels in patients with hematological malignancies.
Kaiafa GD; Saouli Z; Diamantidis MD; Kontoninas Z; Voulgaridou V; Raptaki M; Arampatzi S; Chatzidimitriou M; Perifanis V
Eur J Intern Med; 2012 Dec; 23(8):738-41. PubMed ID: 22920946
[TBL] [Abstract][Full Text] [Related]
12. Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk.
Sud A; Chattopadhyay S; Thomsen H; Sundquist K; Sundquist J; Houlston RS; Hemminki K
Blood; 2019 Sep; 134(12):960-969. PubMed ID: 31395603
[TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukemia after breast cancer: a population-based comparison with hematological malignancies and other cancers.
Beadle G; Baade P; Fritschi L
Ann Oncol; 2009 Jan; 20(1):103-9. PubMed ID: 18647961
[TBL] [Abstract][Full Text] [Related]
14. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
Chang TW; Weaver AL; Shanafelt TD; Habermann TM; Wriston CC; Cerhan JR; Call TG; Brewer JD
Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851
[TBL] [Abstract][Full Text] [Related]
15. [Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004].
Troussard X; Duchenet V; Cornet E; Mouchel D; Malet M; Collignon A
Rev Epidemiol Sante Publique; 2009 Jun; 57(3):151-8. PubMed ID: 19375876
[TBL] [Abstract][Full Text] [Related]
16. The age-risk relationship of hematologic malignancies in patients with rheumatoid arthritis: a nationwide retrospective cohort study.
Lin YC; Chou HW; Tsai WC; Yen JH; Chang SJ; Lin YC
Clin Rheumatol; 2015 Jul; 34(7):1195-202. PubMed ID: 25990004
[TBL] [Abstract][Full Text] [Related]
17. Non-lymphoma hematological malignancies in systemic lupus erythematosus.
Lu M; Bernatsky S; Ramsey-Goldman R; Petri M; Manzi S; Urowitz MB; Gladman D; Fortin PR; Ginzler EM; Yelin E; Bae SC; Wallace DJ; Jacobsen S; Dooley MA; Peschken CA; Alarcón GS; Nived O; Gottesman L; Criswell LA; Sturfelt G; Dreyer L; Lee JL; Clarke AE
Oncology; 2013; 85(4):235-40. PubMed ID: 24107608
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Incidence of Hematologic Malignant Neoplasms Among Breast Cancer Survivors in France.
Jabagi MJ; Vey N; Goncalves A; Le Tri T; Zureik M; Dray-Spira R
JAMA Netw Open; 2019 Jan; 2(1):e187147. PubMed ID: 30657534
[TBL] [Abstract][Full Text] [Related]
19. Risk of solid tumors and hematological malignancy in persons with Turner and Klinefelter syndromes: A national cohort study.
Ji J; Zöller B; Sundquist J; Sundquist K
Int J Cancer; 2016 Aug; 139(4):754-8. PubMed ID: 27061708
[TBL] [Abstract][Full Text] [Related]
20. Blood use in hematologic malignancies: a nationwide overview in Sweden between 2000 and 2010.
Zhao J; Rydén J; Wikman A; Norda R; Stanworth SJ; Hjalgrim H; Edgren G
Transfusion; 2018 Feb; 58(2):390-401. PubMed ID: 29250794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
